// STATE LEGISLATION TRACKER

Arizona SB 1178: naturopathic physicians; drug administration

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: Failed

State: Arizona
Bill: SB 1178
Session: 57th-2nd-regular
Filed: 2026-01-20
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Arizona SB1178 would have expanded naturopathic physicians' drug-administration authority, mainly by allowing IV antibiotics, antivirals, and antifungals. It does not appear to directly change access to compounded peptides, off-label peptide prescribing, telehealth, NP scope, or FDA 503A/503B compounding rules.

Key Points

No direct peptide prescribing or compounding change is apparent
Would have expanded Arizona naturopathic IV drug authority
Mentions pharmacy-compounded IV nutrients, not peptide drugs
Keeps limits around some controlled substances and excluded drug classes
Because it failed, it creates no current access change

What to Watch For

Note Similar future bills could broaden naturopathic authority in ways that indirectly affect peptide-clinic models.

✓

Opportunity Scope expansions for naturopathic physicians may matter for clinics that combine peptides with IV therapies.

Note The bill references pharmacy-compounded IV nutrients, but not 503A or 503B peptide compounding.

Where the Bill Stands

The bill failed in the 2026 Arizona legislative session, so it did not become law.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws